These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27426693)
1. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry. Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693 [TBL] [Abstract][Full Text] [Related]
2. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry. Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176 [TBL] [Abstract][Full Text] [Related]
3. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204 [TBL] [Abstract][Full Text] [Related]
4. Methanolic Extract of Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350 [TBL] [Abstract][Full Text] [Related]
5. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056 [TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413 [TBL] [Abstract][Full Text] [Related]
7. Entry inhibitors and future treatment of hepatitis C. Fofana I; Jilg N; Chung RT; Baumert TF Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381 [TBL] [Abstract][Full Text] [Related]
9. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Anggakusuma ; Colpitts CC; Schang LM; Rachmawati H; Frentzen A; Pfaender S; Behrendt P; Brown RJ; Bankwitz D; Steinmann J; Ott M; Meuleman P; Rice CM; Ploss A; Pietschmann T; Steinmann E Gut; 2014 Jul; 63(7):1137-49. PubMed ID: 23903236 [TBL] [Abstract][Full Text] [Related]
10. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. Behrendt P; Perin P; Menzel N; Banda D; Pfaender S; Alves MP; Thiel V; Meuleman P; Colpitts CC; Schang LM; Vondran FWR; Anggakusuma ; Manns MP; Steinmann E; Pietschmann T Antiviral Res; 2017 Nov; 147():19-28. PubMed ID: 28923507 [TBL] [Abstract][Full Text] [Related]
11. Long-chain fatty acyl-coenzyme A suppresses hepatitis C virus infection by targeting virion-bound lipoproteins. Li X; Li J; Feng Y; Cai H; Li YP; Peng T Antiviral Res; 2020 May; 177():104734. PubMed ID: 32057770 [TBL] [Abstract][Full Text] [Related]
12. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner. Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825 [TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803 [TBL] [Abstract][Full Text] [Related]
14. Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry. Bose M; Kamra M; Mullick R; Bhattacharya S; Das S; Karande AA Sci Rep; 2017 Jun; 7(1):3965. PubMed ID: 28638096 [TBL] [Abstract][Full Text] [Related]
15. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus. Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600 [TBL] [Abstract][Full Text] [Related]
16. The antimalarial ferroquine is an inhibitor of hepatitis C virus. Vausselin T; Calland N; Belouzard S; Descamps V; Douam F; Helle F; François C; Lavillette D; Duverlie G; Wahid A; Fénéant L; Cocquerel L; Guérardel Y; Wychowski C; Biot C; Dubuisson J Hepatology; 2013 Jul; 58(1):86-97. PubMed ID: 23348596 [TBL] [Abstract][Full Text] [Related]
17. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753 [TBL] [Abstract][Full Text] [Related]
20. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors. Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]